Médecins Sans Frontières

New survey finds millions of people affected by TB still diagnosed and treated with outdated tools

Data on 37 countries reveals widespread failure to follow latest international recommendations for policies on prevention, diagnosis, and treatment.

Read More →

Johnson & Johnson TB drug price reduction is important step, and governments need to urgently scale up better treatment

120,707 people signed petitions urging the corporation to drop the price.

Read More →

World TB Day 2020: As coronavirus spreads, preventing and treating TB must remain a priority

As the world grapples with the global pandemic of coronavirus, Doctors Without Borders/Médecins Sans Frontières (MSF) is concerned for vulnerable groups worldwide, like people with tuberculosis (TB), whose lungs are often damaged and immune systems weakened.

Read More →

MSF technical briefs

Médecins Sans Frontières (MSF) updated two of its technical briefs, A rapid TB test for people living with HIV and Making the switch.

Read More →

Good COPs or Bad COPs webinar: Promoting interventions for co-infections and AIDS in 2020 PEPFAR COPs - webinar materials now available online

Treatment Action Group, Médecins Sans Frontières and Health GAP conducted a webinar on 22 January 2020 on how to engage in PEPFAR Country Operational Plans (COPs) advocacy and promote the prioritization of interventions that address HIV co-infections and AIDS.

Read More →

MSF calls on Johnson & Johnson to lower price of lifesaving TB drug

Group protests at New York Stock Exchange as Johnson & Johnson releases earnings report.

Read More →

Good COPs or Bad COPs webinar: Promoting interventions for co-infections and AIDS in 2020 PEPFAR COPs

Treatment Action Group, Médecins Sans Frontières and Health GAP will host a webinar on 22 January 2020 on how to engage in PEPFAR Country Operational Plans (COPs) advocacy and promote the prioritization of interventions that address HIV co-infections and AIDS.

Read More →

Protestors demand Cepheid halve the price of GeneXpert TB tests to US$5

The high cost of GeneXpert tests for TB leaves open a critical gap in the diagnosis of TB and fails to consider volume of sales and public investments in the development of GeneXpert.

Read More →

TB activists disrupt opening of The Union Conference to protest drug corporations keeping life-saving medicines from people

Newer medicines for drug-resistant TB are desperately needed, but barriers to access, including high prices, keep them out of reach for most people around the world. 

Read More →

Price announced for new lifesaving TB drug pretomanid still too high

Pretomanid is just one part of a regimen of multiple drugs that people need. MSF has been calling for the price of a complete DR-TB treatment course to be no higher than $500 per person.

Read More →

Page 1 of 8 · Total posts: 10

1 2 Last→